Cargando…

Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study

BACKGROUND: Pharmaceutical care (PC) through the Dader method (DMet) vs. the usual care process (UCP) significantly reduced psychiatric hospitalizations and emergency service consultations during one year of follow-up of outpatients with bipolar I disorder (BD-I). To date, the effect of long-term PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar-Ospina, Andrea, Amariles, Pedro, Hincapié-García, Jaime A., González-Avendaño, Sebastián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016228/
https://www.ncbi.nlm.nih.gov/pubmed/32072044
http://dx.doi.org/10.1016/j.heliyon.2020.e03333
_version_ 1783496942052966400
author Salazar-Ospina, Andrea
Amariles, Pedro
Hincapié-García, Jaime A.
González-Avendaño, Sebastián
author_facet Salazar-Ospina, Andrea
Amariles, Pedro
Hincapié-García, Jaime A.
González-Avendaño, Sebastián
author_sort Salazar-Ospina, Andrea
collection PubMed
description BACKGROUND: Pharmaceutical care (PC) through the Dader method (DMet) vs. the usual care process (UCP) significantly reduced psychiatric hospitalizations and emergency service consultations during one year of follow-up of outpatients with bipolar I disorder (BD-I). To date, the effect of long-term PC on the use of health services by BD-I patients once pharmacist intervention has ended is unknown. OBJECTIVE: To determine whether the effect of PC measured by the decrease in psychiatric hospitalizations and emergency service consultations is maintained one year after pharmacist intervention ceases. METHODS: This was a retrospective analysis of patients who had previously participated in a randomized, controlled, prospective, single-center clinical trial to compare PC (intervention group) vs. UCP (control group) in BD-I patients. Data were collected from November 2012 to March 2014. The primary outcome was the use of health services measured by the number of psychiatric hospitalizations and emergency service consultations. Descriptive statistics, Student's t-test, Kaplan–Meier function, and Log-Rank test were used. RESULTS: The study included 92 patients: 43 in the intervention group and 49 in the control group. Eleven psychiatric hospitalizations occurred for the intervention group and 19 for the control group. One year after pharmacist intervention ceased, there were no significant differences between the groups in psychiatric hospitalizations (p = 0.261). There were 14 emergency service consultations for the intervention group, and 24 for the control group without significant differences (p = 0.212). CONCLUSIONS: PC through the DMet has no long-term effects on psychiatric hospitalizations and emergency department consultations in patients with BD-I following discontinuation of pharmacist intervention; the effect dissipates when the intervention ceases. Future studies should focus efforts on identifying factors associated with PC that explain why the outcomes derived from this intervention are not maintained in the long term.
format Online
Article
Text
id pubmed-7016228
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70162282020-02-18 Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study Salazar-Ospina, Andrea Amariles, Pedro Hincapié-García, Jaime A. González-Avendaño, Sebastián Heliyon Article BACKGROUND: Pharmaceutical care (PC) through the Dader method (DMet) vs. the usual care process (UCP) significantly reduced psychiatric hospitalizations and emergency service consultations during one year of follow-up of outpatients with bipolar I disorder (BD-I). To date, the effect of long-term PC on the use of health services by BD-I patients once pharmacist intervention has ended is unknown. OBJECTIVE: To determine whether the effect of PC measured by the decrease in psychiatric hospitalizations and emergency service consultations is maintained one year after pharmacist intervention ceases. METHODS: This was a retrospective analysis of patients who had previously participated in a randomized, controlled, prospective, single-center clinical trial to compare PC (intervention group) vs. UCP (control group) in BD-I patients. Data were collected from November 2012 to March 2014. The primary outcome was the use of health services measured by the number of psychiatric hospitalizations and emergency service consultations. Descriptive statistics, Student's t-test, Kaplan–Meier function, and Log-Rank test were used. RESULTS: The study included 92 patients: 43 in the intervention group and 49 in the control group. Eleven psychiatric hospitalizations occurred for the intervention group and 19 for the control group. One year after pharmacist intervention ceased, there were no significant differences between the groups in psychiatric hospitalizations (p = 0.261). There were 14 emergency service consultations for the intervention group, and 24 for the control group without significant differences (p = 0.212). CONCLUSIONS: PC through the DMet has no long-term effects on psychiatric hospitalizations and emergency department consultations in patients with BD-I following discontinuation of pharmacist intervention; the effect dissipates when the intervention ceases. Future studies should focus efforts on identifying factors associated with PC that explain why the outcomes derived from this intervention are not maintained in the long term. Elsevier 2020-02-11 /pmc/articles/PMC7016228/ /pubmed/32072044 http://dx.doi.org/10.1016/j.heliyon.2020.e03333 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Salazar-Ospina, Andrea
Amariles, Pedro
Hincapié-García, Jaime A.
González-Avendaño, Sebastián
Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study
title Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study
title_full Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study
title_fullStr Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study
title_full_unstemmed Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study
title_short Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study
title_sort long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the emdader-tab study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016228/
https://www.ncbi.nlm.nih.gov/pubmed/32072044
http://dx.doi.org/10.1016/j.heliyon.2020.e03333
work_keys_str_mv AT salazarospinaandrea longtermimpactofpharmacistinterventioninpatientswithbipolardisorderextendedfollowuptotheemdadertabstudy
AT amarilespedro longtermimpactofpharmacistinterventioninpatientswithbipolardisorderextendedfollowuptotheemdadertabstudy
AT hincapiegarciajaimea longtermimpactofpharmacistinterventioninpatientswithbipolardisorderextendedfollowuptotheemdadertabstudy
AT gonzalezavendanosebastian longtermimpactofpharmacistinterventioninpatientswithbipolardisorderextendedfollowuptotheemdadertabstudy